Hongxing Xianghe Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 6

Hongxing Xianghe General Information

Description

Provider of drug development services intended to advance epigenetic anti-cancer treatments. The company offers preclinical research services, clinical trial management, regulatory consulting, drug candidate evaluation, oncology research and epigenetic drug development, enabling pharmaceutical companies to accelerate the clinical entry of small molecule inhibitors for advanced malignant tumors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Taicang Xingyao Port, Number 101, Zhaoxi Road, Shaxi Town
  • Taicang
  • Suzhou, Jiangsu 215425
  • China
+86 135
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Taicang Xingyao Port, Number 101, Zhaoxi Road, Shaxi Town
  • Taicang
  • Suzhou, Jiangsu 215425
  • China
+86 135

Hongxing Xianghe Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hongxing Xianghe Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 10-Mar-2026 Completed Generating Revenue
3. Early Stage VC (Series B) 17-Sep-2025 Completed Generating Revenue
2. Early Stage VC (Series A) 13-Aug-2025 Completed Generating Revenue
1. Seed Round 24-May-2022 Completed Startup
To view Hongxing Xianghe’s complete valuation and funding history, request access »

Hongxing Xianghe Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Huaxin Capital Venture Capital Minority
YuanBio Venture Capital Venture Capital Minority
Future Innovation Fund Corporation Minority
Dongxing Capital Growth/Expansion Minority
Northern Light Venture Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Hongxing Xianghe FAQs

  • When was Hongxing Xianghe founded?

    Hongxing Xianghe was founded in 2021.

  • Where is Hongxing Xianghe headquartered?

    Hongxing Xianghe is headquartered in Suzhou, China.

  • What industry is Hongxing Xianghe in?

    Hongxing Xianghe’s primary industry is Drug Discovery.

  • Is Hongxing Xianghe a private or public company?

    Hongxing Xianghe is a Private company.

  • What is Hongxing Xianghe’s current revenue?

    The current revenue for Hongxing Xianghe is .

  • How much funding has Hongxing Xianghe raised over time?

    Hongxing Xianghe has raised $14M.

  • Who are Hongxing Xianghe’s investors?

    Huaxin Capital, YuanBio Venture Capital, Future Innovation Fund, Dongxing Capital, and Northern Light Venture Capital are 5 of 6 investors who have invested in Hongxing Xianghe.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process